236 related articles for article (PubMed ID: 19043838)
21. New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonists.
Hughes A; Barber T; Nelson M
J Infect; 2008 Jul; 57(1):1-10. PubMed ID: 18556070
[TBL] [Abstract][Full Text] [Related]
22. [Integrase inhibition].
Bogner JR
MMW Fortschr Med; 2009 Apr; 151(18):68-71. PubMed ID: 19769082
[No Abstract] [Full Text] [Related]
23. 144-week data released on Gilead's study 934.
AIDS Patient Care STDS; 2007 Aug; 21(8):603-4. PubMed ID: 17902243
[No Abstract] [Full Text] [Related]
24. Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient.
Boyd SD; Maldarelli F; Sereti I; Ouedraogo GL; Rehm CA; Boltz V; Shoemaker D; Pau AK
Antivir Ther; 2011; 16(2):257-61. PubMed ID: 21447876
[TBL] [Abstract][Full Text] [Related]
25. Raltegravir. In HIV-infected in children at least 2 years of age. Only after prior treatment failure.
Prescrire Int; 2014 Sep; 23(152):206. PubMed ID: 25325117
[TBL] [Abstract][Full Text] [Related]
26. Integrase inhibitors for the treatment of HIV infection.
Pace P; Rowley M
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):471-9. PubMed ID: 18600564
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of resistance testing.
Stebbing J; Gazzard BG
J HIV Ther; 2002 Nov; 7(4):75-9. PubMed ID: 12733604
[No Abstract] [Full Text] [Related]
28. Key clinical trials of non-nucleoside reverse transcriptase inhibitors in the treatment of chronic HIV-1 infection in adults.
Williams I
J HIV Ther; 2008 Mar; 13(1):19-23. PubMed ID: 18953269
[No Abstract] [Full Text] [Related]
29. Report from the 2008 joint ICAAC/IDSA meeting. Raltegravir vs. efavirenz in treatment-naive patients.
Sax PE
AIDS Clin Care; 2008 Dec; 20(12):97. PubMed ID: 19274772
[No Abstract] [Full Text] [Related]
30. Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy.
Young B; Fransen S; Greenberg KS; Thomas A; Martens S; St Clair M; Petropoulos CJ; Ha B
Antivir Ther; 2011; 16(2):253-6. PubMed ID: 21447875
[TBL] [Abstract][Full Text] [Related]
31. Raltegravir: the first HIV integrase inhibitor.
Cocohoba J; Dong BJ
Clin Ther; 2008 Oct; 30(10):1747-65. PubMed ID: 19014832
[TBL] [Abstract][Full Text] [Related]
32. Novel integrase inhibitors for HIV.
Prada N; Markowitz M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1087-98. PubMed ID: 20707594
[TBL] [Abstract][Full Text] [Related]
33. HIV integrase inhibitors show potent activity in clinical trials.
Winslow DL
AIDS Alert; 2007 Jan; 22(1):10-1. PubMed ID: 17722343
[No Abstract] [Full Text] [Related]
34. Design issues in initial HIV-treatment trials: focus on ACTG A5095.
Ribaudo HJ; Kuritzkes DR; Schackman BR; Acosta EP; Shikuma CM; Gulick RM
Antivir Ther; 2006; 11(6):751-60. PubMed ID: 17310819
[TBL] [Abstract][Full Text] [Related]
35. Antiretroviral treatment update from the 17th International AIDS Conference.
Boyle B; Cohen C; DeJesus E; Elion R; Frank I; Moyle G; Sax P
AIDS Read; 2008 Nov; 18(11):570-9. PubMed ID: 19062402
[No Abstract] [Full Text] [Related]
36. Data shows long-term nevirapine efficacy and increases in good cholesterol.
AIDS Patient Care STDS; 2007 Aug; 21(8):602. PubMed ID: 17711385
[No Abstract] [Full Text] [Related]
37. [Long-term therapy strategy with raltegravir. Appropriate in all illness phases].
Warpakowski A
MMW Fortschr Med; 2011 May; 153(18):50-1. PubMed ID: 21604599
[No Abstract] [Full Text] [Related]
38. Head-to-head comparison of two first-line regimens and an NRTI-sparing regimen for initial therapy of HIV-1 infection: what should we start?
Pitrak DL
Curr HIV/AIDS Rep; 2009 Feb; 6(1):1-2. PubMed ID: 19149990
[No Abstract] [Full Text] [Related]
39. HIV/AIDS news: comparable anti-HIV antiviral efficacy of Viramune and Efavirenz--the Lancet publishes first large-scale comparison study.
Meyer-Kleinmann J
Infection; 2004 Jun; 32(3):7. PubMed ID: 15230276
[No Abstract] [Full Text] [Related]
40. Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patients.
Jansen A; Colbers EP; van der Ven AJ; Richter C; Rockstroh JK; Wasmuth JC; van Luin M; Burger DM
HIV Med; 2013 Aug; 14(7):449-52. PubMed ID: 23506243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
